https://www.marketscreener.com/quote/stock/GAMIDA-CELL-LTD-46772606/news/Gamida-Cell-Reports-Preliminary-Data-from-Phase-1-Study-of-Natural-Killer-NK-Cell-Therapy-Candidat-45074544/?utm_source=telegram&utm_medium=social&utm_campaign=share